中文 English
Meeting
  • CLQA (CQAF Sub-Committee) 2024 年第1季度会将于3月23日(9:00-12:00)计划在徕博科医药研发(上海)有限公司线下和线上同时召开。会议的议程如下,参会会员将有机会和他们进行探讨交流。期待您的参与! ...
    2024-03-07 14:29:33
  • CQAF 2024 Quarterly Meeting will be held on March 21 (13:30-16:00) at Shanghai/Beijing Office of AZ and on-line. We look forward to your participation! / CQAF 2024 年一季度会将于3月21日(13:30-16:00)在阿斯利康上海、北京办公室和线上同时召开。期待您的参与! ...
    2024-03-06 22:18:23
  • CQAF 2023 Quarterly Meeting will be held on December 22 (13:30-15:30) on-line.  At this quarterly meeting, we will focus on the regulation overview and the quality review of Medical device IND studies and relevant safety reporting. We invited the industry expert Athena and Conny to share with us the relevant topics. Look forward to your participation!  ...
    2023-12-12 16:33:30
  • CLQA (CQAF Sub-Committee) 2023 年第4季度会将于12月9日(9:00-12:00)计划在上海(中科院上海药物所安评中心)、北京(礼来)线下和线上同时召开。会议的议程如下,参会会员将有机会和他们进行探讨交流。期待您的参与! ...
    2023-11-20 11:13:34
  • CQAF 2023 Quarterly Meeting will be held on September 21 (13:30-15:50) in the Conference Room of BI Shanghai Office and Bayer Beijing Office.  At this quarterly meeting, we will first announce the change of CQAF core team and the progress of CQAF collaborative and major projects. Then we will discuss the important quality topic of CAPA. CAPA (Corrective Action & Preventive Action) is a commonly used quality management tool in clinical trials. However, in practice, there are misunderstandings about CAPA understanding and use. For example: Is CAPA required after all issues occur? What kind of issues require CAPA initiation? How to dig out the root causes of issues? How to develop CAPA? How to effectively implement CAPA to avoid of the recurrence of issues? We will discuss around CAPA in the 3rd quarter CQAF meeting. Look forward to your participation!  ...
    2023-09-14 11:34:19
  • CQAF 2023 Annual Meeting will be held in the conference room in MSD Shanghai at 9:00-16:00 on Jun. 20. Please be noted that there will be NO on-line sessions, except for the session ‘Key Points and Determination Principles of Drug Registration Inspection and common issues (Laboratory)’, held on 11:00-12:00am) . Other topics such as ‘The revisions and changes of E6R3, and the considerations to the future quality related work" and “The QA’s insight and consideration to the clinical trial common issues based on the Key Points and Determination Principles of Drug Registration Inspection’ will be discussed. We are looking forward to your participation!  ...
    2023-05-30 20:59:32